Patents by Inventor Thomas C. Drees

Thomas C. Drees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for optimizing ventilation, filtration, and conditioning schemes for buildings
    Patent number: 11913655
    Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on at least one of a level of the one or more characteristics of the first fluid or the one or more characteristics of the second fluid.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: February 27, 2024
    Assignee: Johnson Controls Tyco IP Holdings LLP
    Inventors: Timothy C. Gamroth, Michael J. Wenzel, Mohammad N. ElBsat, David S. Eidson, James Burke, Kirk H. Drees, Thomas M. Seneczko
  • Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant
    Publication number: 20070026024
    Abstract: A physiologically acceptable perfluorocarbon emulsion composition that includes perfluorodecalin and an oxygen-carrying fluorinated surfactant forming a stable emulsion in a continuous aqueous phase. The oxygen-carrying fluorinated surfactant may be fractionated to increase its physiological compatibility, and may further include a fatty acid radical perfluorinated to increase its oxygen-carrying capacity. The perfluorocarbon emulsion composition of the present invention thus exhibits improved stability and efficiency, broadening its application and effectiveness as an artificial oxygen carrier.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 1, 2007
    Inventor: Thomas C. Drees
  • Artificial blood containing perfluoro chemicals in presence of emulsifying agents
    Patent number: 5434191
    Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
    Type: Grant
    Filed: August 23, 1993
    Date of Patent: July 18, 1995
    Assignee: International Therapeutics Inc.
    Inventors: Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees
  • Compounds of perfluoro[3,3,3]propellene and perfluoro hexamethylenetetramine
    Patent number: 5243044
    Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
    Type: Grant
    Filed: February 17, 1989
    Date of Patent: September 7, 1993
    Assignee: International Therapeutics, Inc.
    Inventors: Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees
  • Perfluoro hexamethylenetetramine useful in synthetic blood
    Patent number: 4900824
    Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
    Type: Grant
    Filed: February 17, 1989
    Date of Patent: February 13, 1990
    Assignee: International Therapeutics Inc.
    Inventors: Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees